Episodes

  • The Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS

    The Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS
    Jul 22 2024
    Episode Highlights
    0:15 Introduction
    2:35 Introducing Janelle Bludorn, MS, PA-C
    3:27 Common heat-related illnesses
    8:43 How to screen for individual health-related risks
    15:27 Respiratory consequences of heat
    19:49 The interplay of medicines with heat
    26:49 National Weather Service HeatRisk tool
    32:58 Behavioral interventions for heat-risk patients
    36:27 A FEMA system for heat emergencies?
    38:10 Outro

    For our July episode, we are visited by Duke University’s Janelle Bludorn, PA-C, MS, for a comprehensive overview of heat-related respiratory illnesses.

    Due to climate change in all regions around the world, extreme heat has become a significant environmental and occupational health hazard with heatstroke classified as a medical emergency. Listen in to better understand the serious risks of exposure to high temperatures.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    39 mins
  • Stopping Lung Cancer Before It Starts with Drs. Steven Dubinett & Avrum Spira

    Stopping Lung Cancer Before It Starts with Drs. Steven Dubinett & Avrum Spira
    Jun 24 2024
    Episode Highlights
    0:15 Intro
    3:39 Update in pre-lung cancer genome atlas research
    17:06 Next steps: applying innovations in bronchoscopy
    21:45 When we can anticipate results
    25:05 Understanding the lung’s microbiome
    29:21 Utility of fragmentomics
    31:01 Outro

    Dr. Steven Dubinett at University of California, Los Angeles and Dr. Avrum Spira at Boston University revisit our virtual studio to provide an update on their lung cancer interception research, as currently funded by the American Lung Association and LUNGevity Foundation. With the goal of combating cancer at a preliminary stage, Drs. Dubinett and Spira are focused on refining molecular and imaging markers to help identify high-risk premalignant lesions. These findings hope to lead to future therapeutics halting the progression of cells likely to cause invasive cancer.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    32 mins
  • Changing Landscape of Community-Acquired Pneumonia with Dr. Thomas File

    Changing Landscape of Community-Acquired Pneumonia with Dr. Thomas File
    Jun 6 2024
    0:16 Intro
    2:29 Updated community-acquired pneumonia guidelines
    5:41 Diagnostic tools for CAP following COVID-19
    9:35 Procalcitonin levels as a biomarker
    12:30 The CAP treatment algorithm
    18:36 Best practices for antibiotic stewardship
    20:40 New CAP therapies on the horizon
    22:36 ACIP recommendations for vaccination
    24:30 Remaining areas of CAP uncertainty
    26:30 Final thoughts
    27:25 Outro

    Featuring infectious disease expert Dr. Thomas File of Summa Health in Ohio, this episode delves into how community-acquired pneumonia has been affected by the COVID-19 pandemic. It additionally covers the role and importance of antibiotic stewardship and the concern of ‘superbugs’ due to antimicrobial resistance.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    28 mins
  • Multidisiplinary Asthma Care in High-Risk Communities with Stephanie Lovinsky-Desir, MD, MS

    Multidisiplinary Asthma Care in High-Risk Communities with Stephanie Lovinsky-Desir, MD, MS
    May 7 2024
    Episode Highlights

    0:11 Intro
    1:05 Introducing Stephanie Lovinsky-Desir, MD, MS
    2:09 Understanding asthma endotypes and phenotypes
    5:03 The effect of SMART guideline updates
    11:50 Are pulmonary & allergy specialists adopting it?
    12:46 The value of biologics in asthma care
    18:11 Could they interrupt the atopic march?
    19:53 COVID-19 risks in asthma
    23:24 Environmental and non-viral illness impacts on asthma
    26:11 Research into asthma care inequities
    31:47 HFA-containing metered dose inhalers
    35:37 Outro

    In honor of World Asthma Day, Dr. Stephanie Lovinsky-Desir of Columbia University Irving Medical Center in New York visits our virtual studio to talk about all things asthma. Dr. Lovinsky-Desir, who has a deep understanding of how environmental factors impact children with asthma, touches upon inequities in asthma care, the role of climate change and COVID-19 lessons learned. She also hones in on whether biologic therapies may help interrupt pathways in the atopic march.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    37 mins
  • 2024 State of the Air: Record Highs in US Particle Pollution, with Dr. John Balmes

    2024 State of the Air: Record Highs in US Particle Pollution, with Dr. John Balmes
    Apr 24 2024
    Episode Highlights
    0:16 Intro
    2:17 What caused the particle pollution spike?
    6:28 The health effects of fine particle pollution exposure
    10:23 The new EPA particle pollution standard
    14:27 Improvements to ozone pollution and the Clean Air Act
    18:46 How to advocate for improvement
    20:23 Air quality inequity
    24:03 Reflecting on 25 years, and looking ahead
    25:52 Outro

    Dr. John Balmes, a renowned environmental health sciences expert from the University of California, San Francisco, join Lungcast for a deep dive into the American Lung Association’s newly released 2024 “State of the Air” report. Balmes specifically provides context behind several concerning trends, notably a spike in deadly particle pollution—the highest levels in the past 25 years largely due to wildfires.

    The eye-opening conversation also impresses upon the importance of clean transportation and power generation to help mitigate population-wide risk.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    27 mins
  • Lung Allocation System: Improving Patient Access with Kenneth McCurry, MD & Maryam Valapour, MD, MPP

    Lung Allocation System: Improving Patient Access with Kenneth McCurry, MD & Maryam Valapour, MD, MPP
    Apr 2 2024
    0:16 Intro
    2:28 Recent modifications to the lung allocation score
    5:11 Monitoring chronic graft rejection
    9:23 The rising use of ex vivo lung perfusion
    16:17 The presence of post-COVID patients on the lung transplant waitlist
    21:01 Impact of long Covid on transplant rehabilitation
    22:51 Double lung transplant in bilateral lung cancer—what’s the future?
    26:52 Effect of LAS on lung transplant survival racial disparity
    31:05 What lies ahead in the practice of lung transplantation
    35:00 Outro

    Cleveland Clinic’s Maryam Valapour, MD, MPP, rejoins the broadcast, along with her colleague Kenneth McCurry, MD to discuss optimization of the lung allocation system to continue reducing waitlist times and patient mortality.

    It includes commentary on how recent changes to scoring protocols are expected to impact ongoing disparities related to race and socioeconomic status. They additionally talk about the role of transplantation in patients who have severely damaged lungs resulting from COVID-19 infection, an update since our April 2021 conversation.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    36 mins
  • The Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer

    The Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer
    Feb 12 2024
    Episode Highlights
    0:15 Intro
    3:09 Low-dose CT screening uptake in Canada
    4:45 Evolution of adjuvant, neoadjuvant therapies
    7:10 Reviewing CheckMate 816
    10:56 Reviewing KEYNOTE-671
    12:58 The impact of neoadjuvants on operability
    16:15 Treatment-specific biomarkers for lung cancer
    21:13 The short-term future of lung cancer therapy
    24:31 Outro

    Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network. 

    It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    26 mins
  • Reflecting on the 1964 Surgeon General Report with Viet Le, DMSc, PA-C

    Reflecting on the 1964 Surgeon General Report with Viet Le, DMSc, PA-C
    Jan 29 2024
    Episode Highlights

    0:15 Intro
    1:48 Remembering the 1964 Surgeon General Report
    3:01 The impact of the report on cardiology
    6:47 The strategies and impact of anti-smoking campaigns
    10:33 The modern vaping challenge
    17:38 Outro

    In recognition of 60 years since the 1964 Surgeon General Report—a historic contribution to our understanding of the negative health impacts of cigarette smoking—host Albert Rizzo, MD, meets with preventive cardiology expert Viet Le, DMSc, PA-C to reflect on the myriad of cascading effects delivered by this landmark report.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    18 mins